Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Expanded Access Program to Treat Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07573215
Title field or adapter rule
{'original_value': 'Expanded Access Program to Treat Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:26.810895+00:00
Published At
2026-09-01T00:00:00+00:00
Record Updated At
2026-09-01
Source Retrieved At
2026-10-31T22:17:58.991924+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["PDAC", "PDAC - Pancreatic Ductal Adenocarcinoma", "Metastatic Pancreas Adenocarcinoma", "Pancreatic Cancer", "Pancreatic Cancer Metastatic", "Pancreatic Adenocarcinoma Metastatic", "Pancreatic Adenocarcinoma", "Pancreatic Adenosquamous Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-01", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07573215"
protocolSection.identificationModule.officialTitle
"Expanded Access Program to Treat Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib"
protocolSection.statusModule.overallStatus
"APPROVED_FOR_MARKETING"
protocolSection.designModule.phases
null
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • PDAC (protocolSection.conditionsModule.conditions)
  • PDAC - Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreas Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer Metastatic (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma Metastatic (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenosquamous Carcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'description': 'Oral tablets administered once daily', 'name': 'daraxonrasib', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • daraxonrasib (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.